No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AURA240517C7500
- 0.30
- 0.000.00%
15min DelayTrading May 9 10:30 ET
0.00High0.00Low
0.00Open0.30Pre Close0 Volume23 Open Interest7.50Strike Price0.00Turnover84.78%IV5.83%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.30Time Value100Contract SizeAmericanOptions Type0.4698Delta0.4470Gamma24.57Leverage Ratio-0.0252Theta0.0006Rho11.54Eff Leverage0.0042Vega
Intraday
- 5D
- 1D
News
Aura Biosciences Inc (AURA) Reports Q1 2024 Earnings: A Detailed Financial Overview
Scotiabank Remains a Buy on Aura Biosciences Inc (AURA)
Aura Biosciences: A Strong Buy on Promising Clinical Trials and Market Potential
Aura Biosciences: A Strong Buy on Promising Cancer Treatments and Solid Financials
Aura Biosciences | 10-Q: Quarterly report
Express News | Aura Biosciences Inc: Strong Cash Position Expected to Fund Operations Into Second Half of 2026
Comments
Recent insider selling at Aura Biosciences raises caution, despite positive insider transactions over the past year. Low insider ownership suggests misalignment with shareholder interests. The company's outlook is not promising, with 5 warning signs investors should note.
Aura Biosciences Insider Ups Holding By 232% During Year 1
Gapping up
In reaction to earnings/guidance:
• $Nutanix(NTNX.US$ +15.4%, $Pure Storage(PSTG.US$ +6.8%, $Credo Technology(CRDO.US$ +5.9%, $Signet Jewelers(SIG.US$ +3.6%, $SentinelOne(S.US$ +3.4%, $Five Below(FIVE.US$ +3.2%, $GMS Inc(GMS.US$ +1.7%, $The Scotts Miracle(SMG.US$ +0.9% (also CFO steps down, lowers FY22 FCF guidance, reaffirms all other guidance)
Other news:
• $Turquoise Hill Resources(TRQ.US$ +12.3% (to be acquired by Rio T...
In reaction to earnings/guidance:
• $Nutanix(NTNX.US$ +15.4%, $Pure Storage(PSTG.US$ +6.8%, $Credo Technology(CRDO.US$ +5.9%, $Signet Jewelers(SIG.US$ +3.6%, $SentinelOne(S.US$ +3.4%, $Five Below(FIVE.US$ +3.2%, $GMS Inc(GMS.US$ +1.7%, $The Scotts Miracle(SMG.US$ +0.9% (also CFO steps down, lowers FY22 FCF guidance, reaffirms all other guidance)
Other news:
• $Turquoise Hill Resources(TRQ.US$ +12.3% (to be acquired by Rio T...
9
Gainers:
• $Aura Biosciences(AURA.US$ +13.9% (reports topline data from study of AU-011)
• $Hyzon Motors(HYZN.US$ +8.2% (to collaborate with $Schlumberger(SLB.US$ in decarbonizing oil & gas field operations with high-power fuel cells)
• $Apogee Enterprises(APOG.US$ +6.3% (In reaction to earnings/guidance)
• $GMS Inc(GMS.US$ +6% (In reaction to earnings/guidance)
• $Darden Restaurants(DRI.US$ +4.2% (In reaction to earnings/gui...
• $Aura Biosciences(AURA.US$ +13.9% (reports topline data from study of AU-011)
• $Hyzon Motors(HYZN.US$ +8.2% (to collaborate with $Schlumberger(SLB.US$ in decarbonizing oil & gas field operations with high-power fuel cells)
• $Apogee Enterprises(APOG.US$ +6.3% (In reaction to earnings/guidance)
• $GMS Inc(GMS.US$ +6% (In reaction to earnings/guidance)
• $Darden Restaurants(DRI.US$ +4.2% (In reaction to earnings/gui...
9
2
Related:
IPO-pedia | Chipmaker giant GlobalFoundries seeks $25 bln in IPO
$Informatica(INFA.US$ $GlobalFoundries(GFS.US$ $Fluence Energy(FLNC.US$ $Arteris(AIP.US$ $Rent the Runway(RENT.US$ $Candela Medical(CDLA.US$ $Ensemble Health Partners(ENSB.US$ $LianBio(LIAN.US$ $Solo Brands(DTC.US$ $Airsculpt Technologies(AIRS.US$ $Aura Biosciences(AURA.US$ $Entrada Therapeutics(TRDA.US$ $HireRight(HRT.US$ $Sonendo(SONX.US$ $Udemy(UDMY.US$
IPO-pedia | Chipmaker giant GlobalFoundries seeks $25 bln in IPO
$Informatica(INFA.US$ $GlobalFoundries(GFS.US$ $Fluence Energy(FLNC.US$ $Arteris(AIP.US$ $Rent the Runway(RENT.US$ $Candela Medical(CDLA.US$ $Ensemble Health Partners(ENSB.US$ $LianBio(LIAN.US$ $Solo Brands(DTC.US$ $Airsculpt Technologies(AIRS.US$ $Aura Biosciences(AURA.US$ $Entrada Therapeutics(TRDA.US$ $HireRight(HRT.US$ $Sonendo(SONX.US$ $Udemy(UDMY.US$
Expand 21
Read more